ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Health Technology

Nipro Corp.

Business Summary

Nipro Corp. engages in the manufacture and sale of medical equipment, pharmaceutical products, and glass products. Its operations are carried out through the following segments: Medical related, Pharmaceutical related, Pharma Packaging, and Others. The Medical related segment provides injection and infusion-related products, artificial organ-related products, functional products, and dialysis and diabetes-related products. The Pharmaceutical related segment involves the manufacture and sale of injections, oral agents, and pharmaceutical kit products. The Pharma Packaging segment provides glass products for bottle tubes, ampoules, thermos-use, and lighting. The Others segment includes real estate leasing. The company was founded on July 8, 1954 and is headquartered in Osaka, Japan.

Financial Highlights

Mar 2021 JPYUSD
Gross Profit155,392M1,465.16M
Operating income27,629M260.50M
Income before tax17,519M165.18M
Net income14,210M133.98M
Diluted EPS87.110.82
Dividends Per Share280.26
Total Assets861,838M7,799.43M
Total liabilities687,785M6,224.29M
Total equity161,026M1,457.24M
Operating cash flow66,093M623.18M
Currency in JPYCurrency in USD

Historical Data

 Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021
Revenue 359,699M 395,397M 426,399M 442,516M 455,559M
Gross Profit 115,097M 128,791M 132,042M 149,823M 155,392M
Operating income 28,801M 26,997M 23,828M 26,421M 27,629M
Income before tax 18,324M 17,026M 21,233M -10,158M 17,519M
Net income 11,346M 11,830M 12,136M -12,281M 14,210M
EBITDA 62,836M 62,993M 62,452M 68,246M 70,255M
Diluted EPS 61.33 64.50 66.74 -75.29 87.11
Dividends Per Share 29 28.50 28 13.50 28
Total Assets 754,748M 828,722M 849,273M 834,824M 861,838M
Total liabilities 578,335M 645,233M 677,438M 673,584M 687,785M
Total equity 166,083M 172,622M 161,489M 148,785M 161,026M
Operating cash flow 33,472M 41,046M 41,362M 37,246M 66,093M
 Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021
Revenue 3,321.70M 3,567.52M 3,845.08M 4,070.01M 4,295.39M
Gross Profit 1,062.88M 1,162.03M 1,190.69M 1,377.98M 1,465.16M
Operating income 265.96M 243.58M 214.87M 243.00M 260.50M
Income before tax 169.21M 153.61M 191.46M -93.42M 165.18M
Net income 104.77M 106.73M 109.43M -112.95M 133.98M
EBITDA 580.27M 568.36M 563.16M 627.68M 662.42M
Diluted EPS 0.56 0.58 0.60 -0.69 0.82
Dividends Per Share 0.26 0.25 0.25 0.12 0.26
Total Assets 6,773.29M 7,792.40M 7,672.88M 7,733.07M 7,799.43M
Total liabilities 5,190.11M 6,067.06M 6,120.41M 6,239.48M 6,224.29M
Total equity 1,490.46M 1,623.14M 1,458.99M 1,378.21M 1,457.24M
Operating cash flow 309.10M 370.34M 372.98M 342.56M 623.18M

Valuation Measures

Mar 2021
Operating margin6.06%
Profit margin3.11%

Key executives

  • President & Representative Director: Yoshihiko Sano
  • Director & Manager-Administration: Masanobu Iwasa
  • Director & Deputy Manager-Production Business: Hideo Okamoto
  • Director: Itsuo Akasaki
  • Director & Manager-Production Technology Center: Kazuhiko Sano


  • Nippon Electric Glass Co., Ltd. (9.9%)
  • Nipro Corp. (4.5%)
  • Nomura Asset Management Co., Ltd. (3.1%)
  • T. Rowe Price International Ltd. (2.9%)
  • Asset Management One Co., Ltd. (2.4%)
  • Norges Bank Investment Management (1.9%)
  • Resona Holdings, Inc. (1.8%)
  • The Vanguard Group, Inc. (1.6%)
  • Nipro Employee Stock Ownership Plan (1.3%)
  • Dimensional Fund Advisors LP (1.3%)

Contact Details

  • Website:
  • Address: 3-9-3 Honjo-Nishi, Kita-Ku, Osaka, 531-8510, Japan
  • Phone: +81.6.6372.2331

Related Companies

  • Nipro PharmaPackaging Ural LLC
  • Nipro Europe Group Cos. NV
  • Nipro Vietnam Co., Ltd.
  • Nipro PharmaPackaging (Shanghai) Co., Ltd.
  • Nipro (China) Holdings Co., Ltd.
  • Nipro Board Benefit Trust
  • Nipro Digital Technologies Europe NV
  • Nipro PharmaPackaging France SAS
  • Nipro PharmaPackaging India Pvt Ltd.
  • Nipro ES Pharma KK
  • Nipro Pharmapackaging International NV
  • Nexmed International Co., Ltd.
  • Nipro Medical OOO
  • Anyang Nipro Changda Pharmaceutical Packaging Co., Ltd.
  • OOO Ural Glass Plant
  • Nipro Nordics AB
  • Nipro India Corp. Pvt Ltd.
  • Nipro Medical (India) Pvt Ltd.
  • Nipro JMI Co., Ltd.
  • Nipro Poland Sp zoo
  • Nipro Middle East FZE
  • Nipro Malaysia Sdn. Bhd.
  • Nipro France SA
  • Jilin Nipro Jiaheng Pharmaceutical Packaging Co., Ltd.
  • Nipro Medical Corporation Produtos Medicos Ltda.
  • Nipro Sales (Thailand) Co., Ltd.
  • Nipro Medical of Puerto Rico, Inc.
  • Nipro Trading (Shanghai) Co., Ltd.
  • Nipro South Africa Pty Ltd.
  • Nipro Asia Pte Ltd.


  • Jiang Xi Sanxin Medtec Co Ltd Class A
  • Fresenius Medical Care AG & Co. KGaA
  • Bioteque Corporation
  • Shandong Pharmaceutical Glass Co., Ltd. Class A
  • Stevanato Group SpA
  • Nephros, Inc.
  • Osang Healthcare Co. Ltd.
Last Updated on 20 May, 2022

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more